← Open Payments lookup

NADIA MCFARLANE: Open Payments

NPI 1619175239 · KATY, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$18,428 in 47 payments from 17 companies in 2025. Trend: 2023 $616 · 2024 $409 · 2025 $18,428

Debt forgiveness: $17,410Food & beverage: $1,018
CompanyPaymentsAmount
Neuronetics, Inc.1$17,410
Takeda Pharmaceuticals U.S.A., Inc.9$177
Axsome Therapeutics, Inc.4$108
Corium, LLC4$105
E.R. Squibb & Sons, L.L.C.5$101
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)4$100
Collegium Pharmaceutical, Inc.4$85
Otsuka America Pharmaceutical, Inc.2$59
Supernus Pharmaceuticals, Inc.3$49
Tris Pharma Inc2$44

Products named: NEUROSTAR TMS THERAPY SYSTEM, TRINTELLIX, Auvelity, Azstarys, COBENFY, CAPLYTA, Jornay PM, REXULTI.

Industry payments across TX — which companies pay providers there.